DD
Therapeutic Areas
NovaBiotics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NM001 | Cystic Fibrosis | Phase 2 |
| NM002 | Cystic Fibrosis / Respiratory Conditions | Clinical |
| Cysteamine Bitartrate | Mycobacterial Disease (e.g., Tuberculosis) | Pre-clinical/Research |
| Tinexyl PRO | Toenail Health (Dystrophic/Fungal) | Commercial |